Electra Therapeutics Raises $183M Series C

Core Insights - Electra Therapeutics has successfully raised $183 million in Series C financing to support its pivotal trial for a rare disease candidate [1] Group 1: Financing Details - The Series C financing was co-led by Nextech and EQT Life Sciences, with participation from notable investors including Sanofi, Mubadala Capital, OrbiMed, Blue Owl Capital, and RA Capital Management [1]